BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25594145)

  • 1. Optimal timing for drainage of infected lymphocysts after lymphadenectomy for gynecologic cancer.
    Hiramatsu K; Kobayashi E; Ueda Y; Egawa-Takata T; Matsuzaki S; Kimura T; Sawada K; Yoshino K; Fujita M; Kimura T
    Int J Gynecol Cancer; 2015 Feb; 25(2):337-41. PubMed ID: 25594145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies.
    Ma X; Wang Y; Fan A; Dong M; Zhao X; Zhang X; Xue F
    Arch Gynecol Obstet; 2018 Dec; 298(6):1195-1203. PubMed ID: 30269216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiology of Pelvic Lymphocyst Infection after Lymphadenectomy for Malignant Gynecologic Tumors.
    Kawamura I; Hirashima Y; Tsukahara M; Mori K; Kurai H
    Surg Infect (Larchmt); 2015 Jun; 16(3):244-6. PubMed ID: 25651071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The risk factors analysis and optimal timing for drainage of lymphocele infection after pelvic lymphadenectomy in patients with endometrial cancer].
    Pan MX; Wang YM; Yan Y; Wang Q; Jiang S; Han C; Zhang XH; Xue FX
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1765-1768. PubMed ID: 28647995
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative lymphocysts after lymphadenectomy for gynaecological malignancies: preventive techniques and prospects.
    Achouri A; Huchon C; Bats AS; Bensaïd C; Nos C; Lécuru F
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):125-9. PubMed ID: 22364898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of pelvic lymphocysts as observed by ultrasonography after bilateral pelvic lymphadenectomy.
    Tam KF; Lam KW; Chan KK; Ngan HY
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):87-90. PubMed ID: 18548478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of lymphocyst formation following systematic lymphadenectomy.
    Yamamoto R; Saitoh T; Kusaka T; Todo Y; Takeda M; Okamoto K; Nomura E; Ebina Y; Kaneuchi M; Sakuragi N; Fujimoto S
    Jpn J Clin Oncol; 2000 Sep; 30(9):397-400. PubMed ID: 11095137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies.
    Charoenkwan K; Kietpeerakool C
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007387. PubMed ID: 20091631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nonperitonization and laparoscopic lymphadenectomy for minimizing the incidence of lymphocyst formation after radical hysterectomy for cervical cancer.
    Park NY; Seong WJ; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
    Int J Gynecol Cancer; 2010 Apr; 20(3):443-8. PubMed ID: 20375812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin sclerotherapy of an intractable inguinal lymphocyst.
    Khorram O; Stern JL
    Gynecol Oncol; 1993 Aug; 50(2):244-6. PubMed ID: 7690730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oxidized regenerated methylcellulose on lymphocyst formation and peritoneum in gynecologic cancer patients.
    Ayhan A; Basaran A; Güler TO
    Int J Gynecol Cancer; 2010 Jan; 20(1):23-7. PubMed ID: 20130499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies.
    Charoenkwan K; Kietpeerakool C
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007387. PubMed ID: 28660687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies.
    Charoenkwan K; Kietpeerakool C
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007387. PubMed ID: 24894643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the importance of routine drainage following laparoscopic pelvic lymph node dissection for gynecological malignancies.
    Sakai K; Nakamura M; Yamagami W; Chiyoda T; Kobayashi Y; Nishio H; Hayashi S; Nomura H; Kataoka F; Tominaga E; Banno K; Aoki D
    Int J Gynaecol Obstet; 2021 Jun; 153(3):438-442. PubMed ID: 33259641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroperitoneal drainage after complete Para-aortic lymphadenectomy for gynecologic cancer: a randomized trial.
    Morice P; Lassau N; Pautier P; Haie-Meder C; Lhomme C; Castaigne D
    Obstet Gynecol; 2001 Feb; 97(2):243-7. PubMed ID: 11165589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic lymphocysts following retroperitoneal lymphadenectomy: retroperitoneal partial "no-closure" for ovarian and endometrial cancers.
    Suzuki M; Ohwada M; Sato I
    J Surg Oncol; 1998 Jul; 68(3):149-52. PubMed ID: 9701205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative lymphoceles and lymphatic fistula in gynecologic and breast neoplasms].
    Brun JL
    Bull Cancer; 1995 Sep; 82(9):711-6. PubMed ID: 8535029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy.
    Kondo E; Tabata T; Shiozaki T; Motohashi T; Tanida K; Okugawa T; Ikeda T
    Arch Gynecol Obstet; 2013 Sep; 288(3):587-93. PubMed ID: 23455541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology.
    Nogami Y; Banno K; Adachi M; Kunitomi H; Kobayashi Y; Tominaga E; Aoki D
    Infect Dis Obstet Gynecol; 2019; 2019():9326285. PubMed ID: 30914831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A management scheme for postoperative groin lymphocysts.
    Hoffman MS; Mark JE; Cavanagh D
    Gynecol Oncol; 1995 Feb; 56(2):262-5. PubMed ID: 7896195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.